ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2331

Agreement Between Patient’s and Physician’s Reported Bath Ankylosing Spondylitis Disease Activity Index in Patients with Axial Spondyloarthritis

Liana Ghukasyan1, Adrien Etcheto2, Anna Moltó3 and Maxime Dougados3, 1Rheumatology B Department, Paris-Descartes University, Cochin Hospital, Paris, France, 2Rheumatology B, Rheumatology B Department, Paris-Descartes University, Cochin Hospital, Paris, France, 3Paris Descartes University, Rheumatology Department, Cochin Hospital, AP-HP. INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: outcome measures and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose : The Bath Ankylosing
Spondylitis Disease Activity Index (BASDAI) is the more frequently used index
for evaluating disease activity in Spondyloarthritis (SpA) in clinical practice.
However patients frequently have
questions concerning its wording or need assistance to fill it out. Despite BASDAI
is a patient reported outcome, physicians often ask the questions to the
patients themselves and give their own explanations. Moreover, in patients with
axial SpA a short version of the BASDAI including only questions 1,2,5 and 6
has been proposed (referred here to axial-BASDAI).

These remarks prompted
us to conduct this study aiming to assess the agreement between doctor’s and
patient’s BASDAI and axial-BASDAI in the clinical evaluation of patients with
SpA in daily practice.

Methods:

Study design: this was a cross-sectional
study including patients with axial SpA according to the rheumatologist. Patients
filled out the BASDAI questionnaire in the waiting room. Thereafter, unaware of
the results provided by the patients, the rheumatologist collected another
BASDAI by reading out loud the questions to the patient and giving explanations
if needed.

Statistical analyses: agreement between patient
and physician BASDAI and axial-BASDAI were compared by the intraclass coefficient
of correlation (ICC) and its 95% confidence interval (CI) for continuous
variables and  by the kappa statistics (95%CI) when evaluating the percentage
of patients with high disease activity (e.g. BASDAI
> 4).

Results:

Of the 50 enrolled
patients (mean age: 44
± 10 years; disease duration: 15 ± 10 years) 32 (64%) were male, 40
(81,6%) were B27 positive and 34 (69,4%) had a radiographic sacroiliitis.

The agreement between
patient’s versus physician’s BASDAI
and axial BASDAI were excellent [ICC 0.91 [95% CI, 0.84-0.95]] and ICC
0.94 [95%

CI
,
0.90-0.97]] respectively.  Regarding each question of the BASDAI (see table)
the l
owest
 agreement was found for Q4 (i.e. referring to enthesitis) with an ICC
[95%CI] = 0.51 [0.28 – 0.69].

The agreement between patient and
physician assessment of high disease activity (e.g. BASDAI
>
40 yes/no) was better when considering the axial BASDAI in comparison with the
total BASDAI (see table).  

Table 1

 

Patient

Doctors

ICC

BASDAI 1

 

 

 

Mean (sd)

 

4.91 (2.40)

 

4.95 (2.38)

 

0.94[0.89-0.96]

BASDAI 2

 

 

 

Mean (sd)

 

3.74 (2.34)

 

3.78 (2.55)

 

0.91[0.85-0.95]

BASDAI 3

 

 

 

Mean (sd)

 

2.22 (2.02)

 

2.30 (2.29)

 

0.78[0.64-0.87]

BASDAI 4

 

 

 

Mean (sd)

 

2.91 (2.31)

 

1.85 (2.26)

 

0.51[0.28-0.69]

BASDAI 5+6/2

 

 

 

Mean (sd)

 

3.11 (2.30)

 

2.59 (2.08)

 

0.84 [0.73 – 0.91]

BASDAI total     

Mean (sd)

 

3.38 (1.73)

 

3.09 (1.75)

 

0.91[0.84-0.95]

“Axial” BASDAI              

 

 

 

Mean (sd)

 

39.22 (20.10)

 

37.75 (19.85)

 

0.94 [0.90 – 0.97]

BASDAI total>40

 

 

     

 

17/50 (34%)

13/50 (26%)

0.53[0.27-0.78]

“Axial” BASDAI>40

 

 

 

 

 

21/50 (42%)

20/50 (40%)

0.88[0.74 – 1.00]

 

Conclusion:

Despite an excellent agreement between the physician’s
and  patient’s total BASDAI scores, these data
suggest that:

a)The
fourth question of the BASDAI (e.g. relative to enthesitis) is the less
concordant.

b)The physician’s
reported total BASDAI resulted in
lower number
of patients considered as active patients.

c) Such results should
prompt the scientific community to revise such outcome or at least to provide
clear recommendations on the optimal way to collect it.

 


Disclosure: L. Ghukasyan, None; A. Etcheto, None; A. Moltó, None; M. Dougados, None.

To cite this abstract in AMA style:

Ghukasyan L, Etcheto A, Moltó A, Dougados M. Agreement Between Patient’s and Physician’s Reported Bath Ankylosing Spondylitis Disease Activity Index in Patients with Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/agreement-between-patients-and-physicians-reported-a-bath-ankylosing-spondylitis-disease-activity-index-in-patients-with-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/agreement-between-patients-and-physicians-reported-a-bath-ankylosing-spondylitis-disease-activity-index-in-patients-with-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology